Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization

被引:90
作者
Brown, Jack [1 ,2 ,3 ,4 ]
Brown, Kristen [5 ,6 ]
Forrest, Alan [1 ,2 ,3 ]
机构
[1] SUNY Buffalo, Sch Pharm, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Sch Pharmaceut Sci, Buffalo, NY 14260 USA
[3] SUNY Buffalo, Sch Publ Hlth, Buffalo, NY 14260 USA
[4] Univ Rochester, Med Ctr, Dept Pharm, Rochester, NY 14642 USA
[5] Univ Rochester, Med Ctr, Dept Nursing Practice, Rochester, NY 14642 USA
[6] Univ Rochester, Med Ctr, Golisano Childrens Hosp, Rochester, NY 14642 USA
关键词
REDUCED SUSCEPTIBILITY; PHARMACOKINETICS; PHARMACODYNAMICS; GLYCOPEPTIDES; HEMODIALYSIS; PREDICTORS; EFFICACY; CRITERIA; OUTCOMES; COSTS;
D O I
10.1128/AAC.05609-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of complicated bacteremia (CB) and infective endocarditis (IE). The gold standard treatment for these infections is vancomycin. A vancomycin area under the concentration-time curve from 0 to 24 h (AUC(24))/MIC ratio of >400 has been suggested as a target to achieve clinical effectiveness, and yet to date no study has quantitatively investigated the AUC(24)/MIC ratio and its association with attributable mortality (AM). We performed a review of patients treated for MRSA CB and IE from 1 July 2006 to 30 June 2008. AM was defined as deaths where CB or IE was documented as the main cause or was mentioned as the main diagnosis. Classification and regression tree analysis (CART) was used to identify the AUC(24)/MIC ratio associated with AM. Mann-Whitney and Fisher exact tests were used for univariate analysis, and logistic regression was used for multivariate modeling. The MICs were determined by Etest, and the AUC(24) was determined using a maximum a posteriori probability-Bayesian estimator. A total of 32 CB and 18 IE patients were enrolled. The overall crude mortality and AM were 24 and 16%, respectively. The CART-derived partition for the AUC(24)/MIC ratio and AM was <211. Patients with an AUC(24)/MIC ratio of <211 had a >4-fold increase in AM than patients who received vancomycin doses that achieved an AUC(24)/MIC ratio of 211 (38 and 8%, respectively; P = 0.02). In bivariate analysis the APACHE-II score and an AUC(24)/MIC ratio of <211 were significantly associated with AM. In the multivariate model, the APACHE-II score (odds ratio, 1.24; P = 0.04) and a vancomycin AUC/MIC ratio of <211 (odds ratio, 10.4; P = 0.01) were independent predictors of AM. In our analysis, independent predictors of AM were the APACHE-II score and an AUC(24)/MIC ratio of <211. We believe further investigations are warranted.
引用
收藏
页码:634 / 638
页数:5
相关论文
共 33 条
  • [1] COMPARISON OF RADIOIMMUNOASSAY AND FLUORESCENT POLARIZATION IMMUNOASSAY FOR QUANTITATIVE-DETERMINATION OF VANCOMYCIN CONCENTRATIONS IN SERUM
    ACKERMAN, BH
    BERG, HG
    STRATE, RG
    ROTSCHAFER, JC
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 18 (04) : 994 - 995
  • [2] Determination of minimum inhibitory concentrations
    Andrews, JM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 : 5 - 16
  • [3] Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the international collaboration on endocarditis merged database
    Anguera, I
    Miro, JM
    Cabell, CH
    Abrutyn, E
    Fowler, VG
    Hoen, B
    Olaison, L
    Pappas, PA
    de Lazzari, E
    Eykyn, S
    Habib, G
    Pare, C
    Wang, A
    Corey, R
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (07) : 976 - 981
  • [4] [Anonymous], 2008, M100S19 CLIN LAB STA
  • [5] INFECTIVE ENDOCARDITIS
    BAYER, AS
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 17 (03) : 313 - 320
  • [6] Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
    Craig, WA
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) : 1 - 10
  • [7] Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid
    Craig, WA
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2003, 17 (03) : 479 - +
  • [8] Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
    Drusano, GL
    [J]. NATURE REVIEWS MICROBIOLOGY, 2004, 2 (04) : 289 - 300
  • [9] Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis
    Engemann, JJ
    Friedman, JY
    Reed, SD
    Griffiths, RI
    Szczech, LA
    Kaye, KS
    Stryjewski, ME
    Reller, LB
    Schulman, KA
    Corey, GR
    Fowler, VG
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (06) : 534 - 539
  • [10] Staphylococcus aureus endocarditis -: A consequence of medical progress
    Fowler, VG
    Miro, JM
    Hoen, B
    Cabell, CH
    Abrutyn, E
    Rubinstein, E
    Corey, GR
    Spelman, D
    Bradley, SF
    Barsic, B
    Pappas, PA
    Anstrom, KJ
    Wray, D
    Fortes, CQ
    Anguera, I
    Athan, E
    Jones, P
    van der Meer, JTM
    Elliott, TSJ
    Levine, DP
    Bayer, AS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (24): : 3012 - 3021